Studies and Analyses Clause Samples

POPULAR SAMPLE Copied 1 times
Studies and Analyses. Until completion of the Project, the Applicant shall in a timely manner upon preparing or receiving any study, analysis or report respecting the feasibility or the likely or actual outcomes of the Project, deliver to the Province a copy of such study, analysis or report. The Applicant may make such delivery expressly in confidence, and in that event the Province shall, subject only to the provisions of the Freedom of Information and Protection of Privacy Act (Alberta) regarding access to information (including the provisions thereof protecting the privacy of third party confidential business information and providing for notice to such third parties of a request for access to such Information), the Province shall maintain and safeguard the confidentiality of such study, analysis or report, and shall not make use thereof except for the purpose of administering this Agreement. Such use of any study or analysis may include, but is not limited to the following: (a) consulting with financial institutions to seek clarification that milestones regarding financial commitments have been met, and (b) consulting with any engineering firm involved in the Project to confirm the level of engineering work that has been completed.
Studies and Analyses. The Contractor shall perform studies and analyses. Such studies/analyses may include, but are not limited to logistics/supportability, engineering, financial, operational, business processes, healthcare and benefits systems and applications to include mobile applications, healthcare and benefits analytics, modernization of existing systems and applications (e.g. VistA), and interoperability and/or information sharing of healthcare and benefits systems across Federal agencies as well as public and private healthcare and benefits systems. The Contractor shall perform non-recurring engineering studies and analyses to evaluate the viability of potential solutions, alternatives to various technical issues and challenges, and emerging products or technology. The Contractor shall perform the evaluation of unproven technology applications and identification of potential risks. The development of pre-production or COTS-based prototypes may be required.
Studies and Analyses. Until completion of the Project, the Applicant shall in a timely manner upon preparing or receiving any study, analysis or report respecting the feasibility or the likely or actual outcomes of the Project, deliver to the Province a copy of such study, analysis or report. The Applicant may make such delivery expressly in confidence, and in that event the Province shall, subject only to the provisions of the Freedom of Information and Protection of Privacy Act (Alberta) regarding access to information (including the provisions thereof protecting the privacy of third party confidential business information and providing for notice to such third parties of a request for access to such Information), the Province shall maintain and safeguard the confidentiality of such study, analysis or report, and shall not make use thereof except for the purpose of administering this Agreement. Such use of any study or analysis may PORTIONS OF THIS EXHIBIT WERE OMITTED AND HAVE BEEN FILED SEPARATELY WITH THE SECRETARY OF THE COMMISSION PURSUANT TO AN APPLICATION FOR CONFIDENTIAL TREATMENT UNDER RULE 406 OF THE SECURITIES ACT; [***] DENOTES OMISSIONS. include, but is not limited to the following: (a) consulting with financial institutions to seek clarification that milestones regarding financial commitments have been met, and (b) consulting with any engineering firm involved in the Project to confirm the level of engineering work that has been completed.
Studies and Analyses. The Contractor shall gather data, make assessments, and perform the studies and analyses required to efficiently and effectively accomplish the document imaging-related tasks described within a specific delivery order. Taking into consideration existing systems, document imaging integration requirements, and possible technology solutions, the Contractor shall make recommendations, when appropriate, for enhancement of existing systems or processes and provide assistance within the pertinent areas of study. Specific types of studies and analyses will be defined within individual delivery orders; however, some examples are: system architecture assessments engineering assessments requirements analyses feasibility studies cost/benefit analyses manpower/human factors studies workload analyses market surveys conversion studies concepts of operation
Studies and Analyses. Conduct studies and analyses of current, future, or required capabilities at USSOCOM. Typical tasks may include the conduct of studies and analyses of systems affecting the command and control of tactical units in combat.  Acquisition Program Management. Provide Program Management expertise; such as: program management support and coordination; systems engineering; documentation preparation and coordination; demonstration and test planning and coordination; data collection and reporting; technology evaluation and documentation; proposal review, technical analysis and documentation; knowledge management; and acquisition process improvement.

Related to Studies and Analyses

  • Sampling and Analysis The sampling and analysis of the coal delivered hereunder shall be performed by Buyer upon delivery of the coal to Buyer’s facility, and the results thereof shall be accepted and used as defining the quality and characteristics of the coal delivered under this Agreement and as the Payment Analysis. All analyses shall be made in Buyer’s laboratory at Buyer’s expense in accordance with ASTM standards where applicable, or industry-accepted standards in other cases. Samples for analyses shall be taken in accordance with ASTM standards or other methods mutually acceptable to both parties. Seller shall transmit its “as loaded” quality analysis to Buyer as soon as possible. Seller’s “as-loaded” quality shall be the Payment Analysis only when Buyer’s sampler and/or scales are inoperable, or if Buyer fails to obtain a sample upon unloading. Seller represents that it is familiar with Buyer’s sampling and analysis practices, and that it finds them to be acceptable. Buyer shall notify Seller in writing of any significant changes in Buyer’s sampling and analysis practices. Any such changes in Buyer’s sampling and analysis practices shall, except for ASTM or industry-accepted changes in practices, provide for no less accuracy than the sampling and analysis practices existing at the tune of the execution of this Agreement, unless the Parties otherwise mutually agree. Each sample taken by Buyer shall be divided into four (4) parts and put into airtight containers, properly labeled and sealed. One (1) part shall be used for analysis by Buyer. One (1) part shall be used by Buyer as a check sample, if Buyer in its sole judgment determines it is necessary. One (1) part shall be retained by Buyer until thirty (30) days after the sample is taken (“Disposal Date”), and shall be delivered to Seller for analysis if Seller so requests before the Disposal Date. One (1) part (the “Referee Sample”) shall be retained by Buyer until the Disposal Date. Seller shall be given copies of all analyses made by Buyer by the fifth (5th) business day of the month following the month of unloading. In addition, Buyer shall send Seller weekly analyses of coal unloaded at Buyer’s facilities. Seller, on reasonable notice to Buyer, shall have the right to have a representative present to observe the sampling and analyses performed by Buyer. Unless Seller requests an analysis of the Referee Sample before the Disposal Date, Buyer’s analysis shall be used to determine the quality of the coal delivered hereunder and shall be the Payment Analysis. The Monthly Weighted Averages of specifications referenced in §6.1 shall be based on the individual Shipment analyses. If any dispute arises with regard to the analysis of any sample before the Disposal Date for such sample, the Referee Sample retained by Buyer shall be submitted for analysis to an independent commercial testing laboratory (“Independent Lab”) mutually chosen by Buyer and Seller. For each coal quality specification in question, if the analysis of the Independent Lab differs by more than the applicable ASTM reproducibility standards, the Independent Lab results will govern, and the prior analysis shall be disregarded. All testing of the Referee Sample by the Independent Lab shall be at requestor’s expense unless the Independent Lab results differ from the original Payment Analysis for any specification by more than the applicable ASTM reproducibility standards as to that specification. In such case, the cost of the analysis made by the Independent Lab shall be borne by the party who provided the original Payment Analysis.

  • Studies and Reports All copies in the Seller’s possession of studies and/or reports which have previously been performed in connection with or for the Property, including without limitation, environmental reports, soils studies, seismic studies, physical inspection reports, site plans and surveys, and identification of such studies of which the Seller is aware but that are not in their possession;

  • Special Analyses It is hereby certified that these regulations will not have a significant economic impact on a substantial number of small entities. This certification is based on the fact that it is unlikely that a substantial number of small entities will hold REMIC residual interests. Therefore, a Regulatory Flexibility Analysis under the Regulatory Flexibility Act (5 U.S.C. chapter 6) is not required. It has been determined that this Treasury decision is not a significant regulatory action as defined in Executive Order 12866. Therefore, a regulatory assessment is not required. It also has been determined that sections 553(b) and 553(d) of the Administrative Procedure Act (5 U.S.C. chapter 5) do not apply to these regulations. The principal author of these regulations is ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇. However, other personnel from the IRS and Treasury Department participated in their development. 26 CFR Part 1 Income taxes, Reporting and record keeping requirements.

  • Studies The clinical, pre-clinical and other studies and tests conducted by or on behalf of or sponsored by the Company or its subsidiaries that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus were and, if still pending, are being conducted in accordance in all material respects with all statutes, laws, rules and regulations, as applicable (including, without limitation, those administered by the FDA or by any foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA). The descriptions of the results of such studies and tests that are described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the published data derived from such studies and tests, and each of the Company and its subsidiaries has no knowledge of other studies or tests the results of which are materially inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus. Except as described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, neither the Company nor its subsidiaries has received any notices or other correspondence from the FDA or any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA with respect to any ongoing clinical or pre-clinical studies or tests requiring the termination or suspension of such studies or tests. For the avoidance of doubt, the Company makes no representation or warranty that the results of any studies, tests or preclinical or clinical trials conducted by or on behalf of the Company will be sufficient to obtain governmental approval from the FDA or any foreign, state or local governmental body exercising comparable authority.

  • Risk Analysis The Custodian will provide the Fund with a Risk Analysis with respect to Securities Depositories operating in the countries listed in Appendix B. If the Custodian is unable to provide a Risk Analysis with respect to a particular Securities Depository, it will notify the Fund. If a new Securities Depository commences operation in one of the Appendix B countries, the Custodian will provide the Fund with a Risk Analysis in a reasonably practicable time after such Securities Depository becomes operational. If a new country is added to Appendix B, the Custodian will provide the Fund with a Risk Analysis with respect to each Securities Depository in that country within a reasonably practicable time after the addition of the country to Appendix B.